Research News

Research News | Sep. 27, 2012

New Intel Technology Could Facilitate Lupus Diagnosis

Researchers at Stanford University School of Medicine and Intel Corporation have created a novel silicon chip that can help identify people with a particularly severe form of lupus.

Research News | Sep. 18, 2012

Biomarker-Driven Assessment of Lupus Progression

To help identify biomarkers of early lupus, the researchers aimed to establish a relationship between levels of specific autoantibodies and the evolution of clinical signs of lupus over time.

Research News | Sep. 18, 2012

Second Pregnancy Outcomes in Lupus

The researchers hoped to learn about second pregnancy outcomes in women with lupus, particularly in those whose first pregnancy had an adverse outcome.

Research News | Sep. 18, 2012

Rontalizumab: A Potential New Lupus Therapy

Rontalizumab is a potential new drug to treat lupus. It reduces the effects of the excessive interferon-alpha that is so characteristic of lupus. The researchers hoped to learn about the safety and tolerability of rontalizumab in people with mild lupus disease activity.

Research News | Aug. 30, 2012

New Study by LFA Grantee Reports on Potential Fatigue Biomarker in Lupus

A study published in a recent issue of the journal Lupus characterizes a new potential biomarker of fatigue in people with lupus.

Research News | Aug. 15, 2012

Lupus-Related Changes in Energy Metabolism

People with lupus may experience chronic fatigue, the exact causes of which are yet to be fully understood. There are a number of different energy-producing metabolic processes that may be affected in people with lupus.

Research News | Aug. 15, 2012

Short-Term Use of Hydroxychloroquine Reduces Cholesterol in Lupus

People with lupus are at increased risk of cardiovascular disease, especially when taking steroids. The use of anti-malarial drugs, such as hydroxychloroquine, significantly reduces this risk.

Research News | Aug. 15, 2012

Academic Performance in Children With Lupus

The researchers hoped to determine whether children with lupus have worse academic functioning relative to their peers of similar demographic and socioeconomic background.